Curia Expands Cell Line Development Offering with CHOZN Platform Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies
GlobeNewswire
June 20, 2023
ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with...